26P-31596-02143 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-25
Dose 1 — Pfizer-BioNTech
2021-05-16
Dose 2 — Pfizer-BioNTech
2021-12-16
Dose 3 — Janssen/Johnson & Johnson
2021-12-18
Registered in v-safe
2021-12-18
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school

Adult check-in
2021-12-19
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-12-20
Survey response — days 1–6 daily, dose 3
MedDRA: Arthralgia, Headache, Pain in extremity — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches

Free text: sharp pains that come and go, head, knee, arch of foot, forearm

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Survey response — day 7, dose 3
MedDRA: Arthralgia — Feeling: Good · Fatigue or tiredness

Free text: pain on inside of elbow on arm that was injected

MedDRA releases: 2024-11 · check-in free text available
2022-01-01
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-08
Survey response — day 21, dose 3
MedDRA: Burning sensation, Headache, Injection site pain, Raynaud's phenomenon — Feeling: Good

Free text: Returning pain in injection site lasting 3 days. Raynaud's phenomenon in 3 fingers lasting 30 minutes after being outside. Headache lasting 2 days. Burning sensation in left hand lasting 3 days.

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Survey response — day 28, dose 3
MedDRA: Chest discomfort, Exercise tolerance decreased, Pain in extremity — Feeling: Good

Free text: Difficulty returning to exercise. Chest discomfort when heart rate goes above 120bpm. Intermittent pain in inner right thigh and both feet.

MedDRA releases: 2024-11 · check-in free text available
2022-01-20
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-25	Pfizer-BioNTech	No
2	2021-05-16	Pfizer-BioNTech	No
3	2021-12-16	Janssen/Johnson & Johnson	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-20

Systemic reaction (other): sharp pains that come and go, head, knee, arch of foot, forearm

Release 10 — day 7, dose 3

2021-12-23

Systemic reaction (other): pain on inside of elbow on arm that was injected

Release 10 — day 21, dose 3

2022-01-08

Symptoms: Returning pain in injection site lasting 3 days. Raynaud's phenomenon in 3 fingers lasting 30 minutes after being outside. Headache lasting 2 days. Burning sensation in left hand lasting 3 days.

Release 10 — day 28, dose 3

2022-01-13

Symptoms: Difficulty returning to exercise. Chest discomfort when heart rate goes above 120bpm. Intermittent pain in inner right thigh and both feet.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Burning sensation	·	·	✓
SD	Chest discomfort	·	·	✓
SD	Exercise tolerance decreased	·	·	✓
SD	Headache	·	·	✓
SD	Injection site pain	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Raynaud's phenomenon	·	·	✓
SRO	Arthralgia	·	·	✓
SRO	Headache	·	·	✓
SRO	Pain in extremity	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release